This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Spinal cord
CD2_BENIGN_SPINAL_CORD_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum medullae spinalis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Spinal cord
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Spinal cord
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 500 | 271 | 229 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 54.11 | 53.44 | 54.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 450
- Matched controls
- 4499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
286.0
243
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
3081.4
201.9
180
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
81.8
76
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
74.0
69
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
20.9
74.0
113
71
D33.43
ICD-10 Finland
Spinal cord
+∞
72.9
68
*
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
70.7
66
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
70.7
66
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
299.5
53.4
53
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
62.7
52.1
60
11
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
49.9
47
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
33.4
43.0
56
19
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.7
41.6
138
326
H02AB02
ATC
dexamethasone; systemic
39.1
39.0
49
14
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
+∞
37.0
35
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
34.8
33
*
N03AX16
ATC
pregabalin; oral
3.9
32.7
171
616
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
30.6
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
30.2
169
636
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.3
27.6
92
209
N03AX12
ATC
gabapentin; oral
4.1
27.5
123
377
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
27.0
25.7
35
14
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
24.3
25.6
36
16
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.9
25.4
75
147
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
22.9
25.2
36
17
N02AX02
ATC
tramadol; systemic, rectal
2.9
24.4
235
1246
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
24.2
96
260
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
24.2
23
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
91.8
23.9
26
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
23.1
22
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
11.4
21.3
40
38
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
21.0
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.0
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
219.7
20.8
21
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
19.9
19
*
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
19.9
19
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
19.9
19
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.6
18.5
56
112
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
22.9
18.4
26
12
WX402
NOMESCO Finland
General anaesthesia
3.4
17.9
97
338
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.8
17
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.6
17.7
53
105
SPAT1153
SPAT
Removal of sutures
2.6
17.3
169
856
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
16.8
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
93.6
16.7
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
16.1
110
445
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
15.7
15
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
15.7
15
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
88.2
15.7
17
*
N02AA05
ATC
oxycodone; systemic
3.8
15.4
68
200
R4110
NOMESCO Finland
Physiotherapy
2.5
15.0
139
672
N02BE01
ATC
paracetamol; systemic, rectal
2.9
15.0
397
3229
Z31.5
ICD-10 Finland
Genetic counselling
6.6
14.8
38
62
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
14.7
14
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
154.8
14.5
15
*
M03BX01
ATC
baclofen; systemic
11.0
14.4
27
26
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
14.2
56
148
WF002
NOMESCO Finland
Radical radiotherapy
55.1
13.9
16
*
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
13.6
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
AA1AD
NOMESCO Finland
CT of head and brain
2.5
13.6
127
614
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.8
13.5
38
70
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.6
13.3
34
55
L28
ICPC
Limited function/disability (L)
2.9
13.3
92
371
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
13.3
57
163
XKD00
NOMESCO Finland
Uroflowmetry
3.0
13.0
81
306
S18
ICPC
Laceration/cut
2.2
13.0
197
1193
UKC02
NOMESCO Finland
Cystoscopy
3.0
12.8
77
286
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
71.9
12.7
14
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
12.6
12
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
12.5
170
976
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
12.4
57
173
ZXC40
NOMESCO Finland
Use of ultrasound
27.6
12.1
16
6
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.9
12.0
20
15
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
12.0
60
195
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
11.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
M54.5
ICD-10 Finland
Low back pain
2.1
11.5
165
964
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
123.0
11.5
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
11.5
73
280
NK6AN
NOMESCO Finland
Total body bone isotope imaging
36.0
11.3
14
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
44.5
11.0
13
*
D33.30
ICD-10 Finland
Acoustic neuroma
18.4
10.8
16
9
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
10.6
28
48
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
10.5
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
10.5
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
10.2
177
1102
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
10.1
63
238
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
10.1
190
1224
WX110
NOMESCO Finland
Local anesthesy
2.0
10.0
316
2457
JN4BD
NOMESCO Finland
Extensive body CT
4.6
9.9
34
79
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
5.4
9.9
29
57
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.6
9.5
42
124
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
18.0
9.5
14
8
A04AA02
ATC
granisetron; systemic, transdermal
102.1
9.4
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
102.1
9.4
10
*
ZZR00
NOMESCO Finland
Flap of skin
30.7
9.4
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.6
9.4
32
74
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
+∞
9.4
9
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
9.4
9
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
9.4
9
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
9.4
9
*
M48.0
ICD-10 Finland
Spinal stenosis
2.7
9.3
67
275
Z3231
NOMESCO Finland
Registered nurse
2.1
9.2
124
695
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
9.0
66
276
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
9.0
134
784
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
51.0
8.7
10
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.7
8.6
60
240
Z3226
NOMESCO Finland
Physiotherapist
2.3
8.6
90
447
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
8.6
79
369
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
28.1
8.5
11
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
28.1
8.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
5.0
8.5
26
54
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.5
8.5
12
6
A06AD11
ATC
lactulose; oral
2.6
8.5
66
284
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.3
8.5
30
73
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
+∞
8.4
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
+∞
8.4
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
8.3
138
836
N06AX21
ATC
duloxetine; oral
2.6
8.2
61
254
TAB00
NOMESCO Finland
Lumbar puncture
4.2
8.2
30
75
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
12.0
8.1
14
12
G82.2
ICD-10 Finland
Paraplegia, unspecified
17.6
8.1
12
7
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
34.0
8.1
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
8.0
168
1102
M54.2
ICD-10 Finland
Cervicalgia
3.2
8.0
41
137
JN4AD
NOMESCO Finland
Body CT examination
5.0
7.9
24
50
R4120
NOMESCO Finland
Occupational therapy
3.2
7.6
38
125
HAC20
NOMESCO Finland
Total mastectomy
81.4
7.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
81.4
7.4
8
*
2312
FHL
Extirpation or destruction
81.4
7.4
8
*
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
81.4
7.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
+∞
7.3
7
*
N76
ICPC
Neoplasm nervous system unspecified
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
N75
ICPC
Benign neoplasm nervous system
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
ZXA05
NOMESCO Finland
Left side
1.9
7.3
112
656
R33
ICD-10 Finland
Retention of urine
3.0
7.3
41
145
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
7.2
26
65
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
30.5
7.2
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
7.2
31
91
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.8
7.1
29
81
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
7.1
84
440
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
7.1
57
248
M03BX02
ATC
tizanidine; oral
1.7
7.1
275
2154
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
7.0
28
77
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
6.8
17
28
N18
ICPC
Paralysis/weakness
5.8
6.8
18
32
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
9.5
6.8
13
14
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.8
133
844
N06AA09
ATC
amitriptyline; systemic
2.5
6.8
53
229
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
40.7
6.8
8
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
17.0
6.8
10
6
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
6.8
63
298
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.6
6.7
16
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.6
124
777
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
6.5
39
145
A02BC02
ATC
pantoprazole; systemic
1.7
6.5
271
2137
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
70.8
6.4
7
*
L03
ICPC
Low back symptom/complaint
1.9
6.4
110
667
B01AB05
ATC
enoxaparin; parenteral
1.8
6.3
116
719
ZXD35
NOMESCO Finland
Usual procedure
4.2
6.3
22
54
G04BE03
ATC
sildenafil; oral
18.3
6.3
9
5
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
6.3
6
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
6.3
6
*
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.2
6.2
18
36
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
6.2
20
45
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
6.2
30
97
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
6.2
46
194
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
6.1
108
658
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.1
156
1068
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
12.7
6.1
10
8
N28
ICPC
Limited function/disability (N)
6.8
6.1
14
21
R52.2
ICD-10 Finland
Other chronic pain
4.1
6.1
22
56
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
107
122
10.89
89.30
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
47
26
19.85
59.28
1.6
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
234
1066
3.25
36.40
2.2
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
259
1279
3.13
34.60
2.5
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
204
890
3.18
33.64
3.7
3.3
%
91.2
90.2
0.23
197
862
(3003396) Base excess in Arterial blood by calculation
120
384
3.80
32.34
8.6
9.0
mmol/l
1.5
1.4
0.13
94
301
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
289
1606
2.89
29.74
7.1
5.4
mmol/l
1.2
1.2
0.47
274
1429
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
294
1668
2.85
28.75
4.2
3.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
305
1780
2.83
27.97
8.2
5.9
mmol/l
1.2
1.2
0.71
274
1538
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
182
816
2.93
27.65
2.2
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
341
2294
2.53
20.59
6.4
4.4
mmol/l
6.4
6.7
1.89
323
2119
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
65
210
3.41
16.73
11.8
9.9
%
1.4
1.5
0.47
65
210
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
64
206
3.42
16.56
11.9
10.0
%
0.7
0.7
0.23
64
206
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
220
1312
2.21
16.33
3.9
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
238
1475
2.17
15.92
7.8
9.0
inr
1.2
1.3
0.34
45
429
(3024561) Albumin [Mass/volume] in Serum or Plasma
241
1513
2.14
15.46
5.3
3.6
g/l
35.7
36.2
0.65
227
1407
(3026008) Bacteria identified in Urine by Culture
183
1052
2.17
14.53
3.6
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
340
2482
2.16
14.15
6.4
4.0
e6/l
968.4
1218.6
—
5
40
(3023368) Bacteria identified in Blood by Culture
161
889
2.20
14.08
4.7
3.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
173
995
2.13
13.55
3.6
2.8
e6/l
0.4
0.4
0.05
144
738
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
122
615
2.30
13.21
2.8
2.5
e6/l
0.7
1.0
1.02
72
343
(3013650) Neutrophils [#/volume] in Blood by Automated count
300
2129
2.02
12.97
9.3
6.8
e9/l
4.1
4.2
0.49
263
1867
(3000850) Epithelial cells [#/volume] in Urine
140
754
2.19
12.87
2.8
2.2
e6/l
2.9
6.7
2.90
124
658
(3002582) Erythrocytes [#/volume] in Urine
183
1102
2.04
12.48
3.8
2.8
e6/l
17.8
129.8
1.16
147
842
(36304419) Bacteria [Presence] in Urine
166
973
2.06
12.13
3.8
2.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
17
9.07
12.06
1.9
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
105
522
2.28
11.62
3.7
3.0
mmol/l
0.8
0.8
0.53
100
484
(3018095) Leukocytes [#/volume] in Urine
206
1321
1.95
11.54
4.5
3.3
e6/l
30.1
129.8
2.13
157
912
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
111
570
2.22
11.34
3.0
2.7
e6/l
1.7
2.5
0.52
62
298
(3044290) Cell count panel - Cerebral spinal fluid
31
80
4.07
11.00
1.8
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
262
1855
1.87
10.55
7.7
3.9
umol/l
10.3
11.2
1.47
252
1734
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
37
5.59
10.48
2.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
15
8.87
10.27
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
372
2963
2.00
10.27
8.9
5.3
u/l
73.5
74.4
0.26
364
2729
(3037467) Urinalysis macro (dipstick) panel - Urine
344
2673
1.92
10.17
5.5
4.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
169
1050
1.92
10.14
4.1
3.1
ph
7.4
7.4
0.28
28
169
(3002256) Pathology report gross observation
71
316
2.45
10.03
1.2
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
124
696
2.04
9.94
2.7
2.4
mosm/kgh2o
519.4
552.0
0.93
108
582
(3001604) Monocytes [#/volume] in Blood
264
1907
1.81
9.66
5.9
5.5
e9/l
0.6
0.6
0.50
219
1670
(3011397) Hemoglobin [Presence] in Urine by Test strip
149
901
1.93
9.61
4.2
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
55
224
2.64
9.32
7.4
7.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
54
4.42
9.21
3.0
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
271
1991
1.79
9.20
6.2
5.9
e9/l
0.2
0.2
0.51
230
1768
(3006315) Basophils [#/volume] in Blood
263
1917
1.78
9.16
6.0
5.6
e9/l
0.0
0.0
0.27
217
1681
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
187
1238
1.82
8.97
2.4
2.1
u/l
215.1
227.9
0.06
180
1166
(3016018) Differential panel - Cerebral spinal fluid
19
39
5.02
8.90
1.8
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
178
1163
1.82
8.90
4.0
2.0
mmol/l
2.4
2.3
0.99
161
973
(3018677) aPTT in Platelet poor plasma by Coagulation assay
103
562
2.05
8.84
1.7
1.9
s
30.2
29.5
0.32
103
543
(3019198) Lymphocytes [#/volume] in Blood
265
1966
1.74
8.42
6.0
5.6
e9/l
2.0
1.9
0.17
221
1743
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
205
2.60
8.36
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
461
4086
2.64
8.29
19.0
11.3
mg/l
21.6
21.7
0.02
384
3073
(3000991) Gas panel - Venous blood
60
272
2.37
8.11
11.5
8.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
85
445
2.10
8.11
4.8
5.1
mmol/l
1.0
1.0
0.08
79
401
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
165
2.69
7.64
15.2
14.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
154
1001
1.78
7.63
5.1
3.5
estimate
0.0
0.0
0.50
49
320
(3009261) Glucose [Presence] in Urine by Test strip
259
1946
1.69
7.56
4.8
3.4
estimate
0.0
0.0
0.50
46
318
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
191
2.55
7.50
4.2
1.4
ug/l
3.7
4.3
0.10
36
147
(3019069) Monocytes/100 leukocytes in Blood
240
1782
1.67
7.22
6.6
6.0
%
8.7
8.5
0.33
226
1671
(3013707) Erythrocyte sedimentation rate by Westergren method
365
3031
1.76
7.13
4.5
4.0
mm/h
10.0
10.8
0.64
343
2784
(3035350) Ketones [Presence] in Urine by Test strip
254
1919
1.66
7.10
4.5
3.4
estimate
0.0
0.0
0.00
44
329
(42870588) Differential panel, method unspecified - Blood
178
1232
1.69
6.93
6.6
5.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
232
1720
1.65
6.93
6.4
5.8
%
0.7
0.7
0.02
219
1604
(40758558) Short blood count panel - Blood
134
857
1.77
6.93
6.9
5.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
53
3.89
6.87
2.9
1.2
nmol/l
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
237
1773
1.64
6.79
6.4
5.7
%
2.8
3.0
0.53
223
1652
(3035637) Corticotropin [Mass/volume] in Plasma
16
36
4.56
6.75
2.1
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
346
2852
1.69
6.72
4.1
3.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
242
1830
1.62
6.57
6.5
5.8
%
28.3
28.6
0.11
228
1709
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
533
1.89
6.53
6.5
6.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
150
1007
1.70
6.47
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
37
149
2.60
6.43
7.8
4.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
250
1916
1.61
6.35
5.7
4.7
estimate
0.0
0.0
0.00
48
327
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
13
26
5.11
6.25
1.8
1.2
mmol/l
2.6
1.7
1.34
13
26
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
218
1623
1.61
6.20
2.4
2.2
nmol/l
77.7
77.0
0.12
205
1433
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
104
641
1.79
6.03
3.3
2.0
mmol/l
2.4
2.4
1.16
90
553
(3018010) Neutrophils/100 leukocytes in Blood
237
1820
1.57
5.80
6.2
5.6
%
56.9
56.7
0.10
225
1707
(3049717) Cytology report of Urine Cyto stain
27
102
2.74
5.33
2.2
1.6
—
—
—
0
0
(3015736) pH of Urine
203
1528
1.55
5.29
4.2
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
205
1553
1.54
5.16
3.6
3.4
ng/l
24.6
60.6
0.88
133
1057
(40768797) Stomach Pathology biopsy report
90
556
1.75
5.13
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
46
3.56
4.93
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
76
461
1.76
4.60
2.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
365
3173
1.56
4.57
4.6
3.8
pmol/l
14.8
14.8
0.20
333
2903
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
170
1266
1.52
4.50
4.0
2.8
u/l
35.8
31.2
0.52
165
1208
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
88
2.69
4.46
1.6
1.6
—
—
—
0
0
(4024509)
12
30
4.07
4.46
1.5
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
128
912
1.54
4.10
2.3
2.1
mg/l
3.1
3.0
0.11
107
763
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
206
2.02
4.00
1.8
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
149
1104
1.50
3.96
3.0
2.9
ng/l
947.1
1044.6
0.17
120
931
(3042936) Bacteria identified in Isolate by Culture
82
530
1.65
3.94
2.4
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
153
2.17
3.87
2.0
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
346
1.77
3.73
4.0
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
61
2.85
3.72
2.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
91
2.48
3.69
1.9
2.7
u/ml
0.4
0.4
—
9
50
(40761511) CBC panel - Blood by Automated count
464
4350
1.93
3.62
18.0
10.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
75
2.59
3.50
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
95
2.38
3.38
3.6
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
84
568
1.58
3.36
2.3
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
326
1.74
3.34
3.7
3.0
—
—
—
0
0
(3019225) pH of Specimen
59
366
1.69
3.31
3.6
3.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
43
3.08
3.27
1.8
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
102
725
1.51
3.26
1.4
1.3
iu/ml
21.7
35.6
1.33
29
226
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
158
1225
1.42
3.23
3.5
2.2
u/l
51.8
58.3
2.03
147
1127
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
418
3840
1.54
3.19
5.5
4.5
mu/l
1.8
2.2
0.62
384
3527
(3021589) Normoblasts [#/volume] in Blood
209
1708
1.38
3.12
10.2
8.1
e9/l
0.0
0.0
0.83
156
1397
(3007164) IgA [Mass/volume] in Serum or Plasma
108
786
1.48
3.07
1.3
1.3
g/l
2.3
2.5
0.62
66
478
(3021960) Folate [Moles/volume] in Serum or Plasma
124
928
1.45
3.05
1.5
1.5
nmol/l
21.6
21.2
0.11
109
794
(1761868) Lipid panel - Serum or Plasma
120
1564
0.69
3.04
2.9
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
186
1502
1.38
2.95
4.9
3.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
230
1.80
2.93
2.1
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
121
908
1.44
2.93
5.8
3.5
kg/l
1.0
1.0
0.47
16
136
(3022313) Gas panel - Capillary blood
33
179
1.90
2.90
2.8
4.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
319
1.67
2.80
2.0
1.9
ml/min/173m2
96.1
69.2
0.42
19
130
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
421
3901
1.50
2.79
16.1
10.0
ml/min/173m2
85.9
82.7
2.02
372
3117
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
48
299
1.67
2.68
3.0
3.1
ng/l
151.5
159.9
0.07
42
274
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
55
2.59
2.63
2.4
2.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
48
301
1.66
2.62
2.7
2.5
au/ml
23.3
20.5
—
6
10
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
135
1054
1.38
2.58
4.8
3.6
%
20.1
23.7
2.06
74
453
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
857
1.41
2.56
1.7
1.8
mg/l
1.1
1.0
0.17
84
643
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
66
453
1.53
2.48
2.3
2.3
%
21.2
23.9
0.98
58
397
(3006462) Nitrate [Presence] in Urine
7
16
4.42
2.48
10.1
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
59
395
1.56
2.48
1.4
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
25
132
1.94
2.40
1.4
1.5
mu/l
289.8
265.9
0.31
25
120
(3048689) Calprotectin [Mass/mass] in Stool
70
491
1.49
2.38
1.7
2.2
ug/g
106.7
110.0
0.05
53
377
(3001122) Ferritin [Mass/volume] in Serum or Plasma
207
1744
1.32
2.37
2.7
2.7
ug/l
102.2
111.2
0.44
192
1605
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
119
1.98
2.34
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
51
336
1.58
2.30
3.1
3.1
mmol/l
2.4
2.1
0.25
44
266
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
120
1.96
2.29
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
29
3.14
2.23
1.3
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
29
3.14
2.23
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
36
2.81
2.21
1.8
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
194
1632
1.31
2.21
2.1
1.9
pmol/l
93.3
95.7
0.32
105
843
(4211845)
7
19
3.72
2.15
10.1
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
416
3896
1.40
2.13
5.7
5.8
mmol/mol
38.3
39.8
3.42
391
3636
(3007461) Platelets [#/volume] in Blood
482
4660
1.95
2.12
28.0
16.7
e9/l
251.4
250.0
0.19
477
4538
(42529406) Shigella sp [Presence] in Stool by Culture
23
124
1.90
2.10
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
231
1.65
2.09
2.7
3.8
mmol/l
2.3
2.0
0.14
24
170
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
395
1.50
2.07
2.6
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
309
2779
1.29
2.06
4.1
3.0
u/l
46.0
44.4
0.20
303
2606
(3037121) Protein [Mass/volume] in Urine
23
125
1.88
2.06
2.6
2.6
g/l
0.1
0.2
0.33
12
39
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
15
4.04
2.04
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
15
4.04
2.04
1.2
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
15
4.04
2.04
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
15
4.04
2.04
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
116
918
1.34
2.01
1.3
1.3
u/ml
2.4
1.3
0.28
34
255
(3000963) Hemoglobin [Mass/volume] in Blood
482
4667
1.91
2.00
28.1
16.8
g/l
135.4
137.7
3.24
482
4592
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
297
2664
1.28
1.99
2.9
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
126
1011
1.33
1.99
3.1
2.4
umol/l
344.2
7354.8
4.19
114
885
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
51
2.39
1.96
1.4
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
43
284
1.56
1.95
2.3
2.2
e9/l
67.3
69.8
0.21
32
223
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
56
392
1.48
1.95
2.6
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
42
276
1.57
1.94
5.2
4.5
%
0.8
0.6
0.16
14
61
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.58
1.94
1.8
3.8
%
103.8
94.6
—
5
11
(3012544) pH of Venous blood
51
351
1.50
1.92
3.2
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
327
1.52
1.90
3.6
2.1
u/l
31.8
34.4
0.16
42
266
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
52
2.34
1.89
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
91
701
1.36
1.87
1.3
1.3
u/ml
3.3
11.4
2.47
41
274
(3022948) Iron [Moles/volume] in Serum or Plasma
75
560
1.40
1.86
2.4
2.2
umol/l
13.4
13.8
0.19
69
516
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
40
2.53
1.84
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
40
2.53
1.84
1.2
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
53
2.30
1.82
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.73
2.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
82
1.98
1.71
2.1
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
37
244
1.56
1.71
3.9
2.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
501
1.39
1.66
2.2
2.2
g/l
2.3
2.4
0.45
62
467
(3051611) Lipemic interference index of Serum or Plasma
7
25
2.82
1.65
1.6
2.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
462
4453
1.49
1.59
12.6
8.5
u/l
26.1
26.6
0.29
451
4281
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
26
2.72
1.58
2.3
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
156
1324
1.26
1.57
5.5
3.6
ug/l
2.2
1.8
0.89
140
1188
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
64
2.06
1.55
2.3
1.3
pmol/l
62.2
56.8
0.26
13
64
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
33
2.45
1.54
5.4
3.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
15
3.36
1.52
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
554
1.35
1.51
1.3
1.4
titre
496.0
531.2
0.07
15
132
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
117
1.74
1.47
2.7
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
339
1.43
1.44
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
92
739
1.30
1.44
3.3
2.6
ug/l
0.6
0.7
0.60
66
463
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
22
2.75
1.44
16.8
9.5
mmol/l
0.6
0.6
—
6
22
(3026389) Candida sp identified in Specimen by Organism specific culture
9
39
2.33
1.43
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
39
2.33
1.43
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
40
2.27
1.40
5.6
4.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
52
384
1.40
1.40
2.3
2.1
%
1.7
1.7
0.00
44
349
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
53
2.10
1.39
1.4
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
104
1.76
1.38
2.4
1.7
iu/l
4.5
6.0
—
7
37
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
161
0.49
1.38
1.3
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
41
2.22
1.37
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.63
1.37
1.7
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.63
1.37
1.7
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
47
2.15
1.34
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
42
2.16
1.34
2.2
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
40
0.00
1.33
0.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
145
1.61
1.31
1.8
1.6
—
—
—
0
0
(4034850)
24
153
1.60
1.31
10.1
10.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
210
1.51
1.31
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
43
2.11
1.31
1.7
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
24
2.52
1.30
1.2
1.3
—
—
—
0
0
(44790047)
8
34
2.37
1.29
2.6
1.6
—
—
—
0
0
(44790049)
8
34
2.37
1.29
2.6
1.6
—
—
—
0
0
(44806118)
8
34
2.37
1.29
2.6
1.6
—
—
—
0
0
(44790048)
8
34
2.37
1.29
2.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
365
1.38
1.27
2.7
2.4
ug/l
4.8
7.4
0.78
44
323
(4268621)
9
44
2.06
1.27
2.0
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
44
2.06
1.27
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
35
2.31
1.27
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
155
1.58
1.25
1.3
2.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
70
1.88
1.25
8.9
3.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
213
1.49
1.24
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
230
1.47
1.23
1.4
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
11
56
1.99
1.23
1.0
1.1
u/ml
8.5
1.5
—
6
20
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
132
1.62
1.22
1.1
1.3
g/l
2.8
3.0
0.26
14
102
(3002385) Erythrocyte distribution width [Ratio]
363
3423
1.22
1.20
22.2
13.7
%
13.7
13.6
1.10
357
3355
(40760892) CBC W Ordered Manual Differential panel - Blood
108
906
1.24
1.19
4.3
3.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
125
1.63
1.19
1.2
1.3
g/l
8.8
10.8
1.33
14
106
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
(3013512) EKG study
134
1158
1.21
1.12
4.4
3.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
252
1.42
1.12
5.2
4.7
%
0.0
1.8
—
10
48
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
21
2.39
1.09
3.8
3.8
umol/l
27.2
31.9
—
5
14
(3021440) Promyelocytes/100 leukocytes in Blood
36
262
1.40
1.09
5.6
4.6
%
0.1
0.1
0.13
11
52
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
137
1.56
1.07
1.1
1.3
g/l
6.4
7.4
2.33
14
104
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
137
1.56
1.07
1.1
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
137
1.56
1.07
1.1
1.3
g/l
3.2
3.8
2.36
14
100
(3025941) Bacteria identified in Stool by Culture
30
212
1.44
1.06
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
90
1.69
1.05
1.5
1.4
ug/g
213.3
330.6
—
9
48
(3017704) Immunofixation for Urine
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
60
1.85
1.03
1.0
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
68
1.78
1.01
1.2
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
426
4110
1.25
0.98
4.9
4.4
mmol/l
5.9
5.9
0.06
395
3765
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
116
1.57
0.98
1.3
1.1
u/ml
4.8
12.9
—
5
15
(3027315) Oxygen [Partial pressure] in Blood
12
69
1.76
0.97
15.9
4.1
kpa
7.7
8.2
0.67
12
69
(3013290) Carbon dioxide [Partial pressure] in Blood
12
69
1.76
0.97
15.9
4.1
kpa
5.4
5.1
0.29
12
69
(3044927) Protein electrophoresis panel - Urine
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
252
1.37
0.95
4.8
4.5
%
0.4
0.2
—
9
48
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
513
1.26
0.92
1.8
1.7
%
1.6
1.5
0.13
55
448
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
300
0.69
0.91
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
90
764
1.22
0.91
4.7
3.7
ng/l
337.6
479.6
0.25
74
571
(3011648) Oxygen content in Venous blood
6
29
2.08
0.89
1.7
1.7
%
9.0
11.2
—
6
29
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
299
1.33
0.89
1.3
1.2
iu/ml
83.7
121.6
0.37
14
128
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
42
1.92
0.89
1.1
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
79
1.66
0.88
2.5
2.8
kpa
8.6
8.0
0.58
13
74
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
535
1.25
0.87
4.8
4.5
%
31.4
31.8
0.13
50
357
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
137
1.48
0.85
1.9
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
31
1.95
0.84
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
73
1.66
0.82
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
130
1.48
0.82
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
81
1.62
0.82
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
58
1.74
0.80
6.1
4.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
66
1.68
0.79
1.8
1.8
%
50.6
62.9
1.16
11
66
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
75
1.61
0.75
1.8
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
3.8
1.3
ug/l
15.6
14.6
—
5
24
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
20
142
1.43
0.73
2.3
2.3
ug/l
592.7
577.4
0.01
20
131
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
56
1.62
0.72
2.0
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
68
1.63
0.72
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
68
1.63
0.72
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
265
1.30
0.72
1.5
1.4
—
—
—
0
0
(4306422)
9
57
1.59
0.71
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
408
0.77
0.71
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
35
275
1.29
0.70
6.8
2.9
e9/l
4.2
4.0
0.19
26
211
(3005570) Glucose [Moles/volume] in Urine
7
41
1.72
0.70
2.4
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
135
1.42
0.70
1.5
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
61
1.65
0.69
1.0
1.1
u/ml
3.0
4.3
—
5
26
(4062490)
7
42
1.68
0.68
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
207
1.32
0.65
3.7
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
3.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
394
3816
1.15
0.63
20.9
12.4
%
39.4
40.6
1.55
282
2771
(3007566) Smooth muscle Ab [Titer] in Serum
6
104
0.57
0.62
1.0
1.2
—
101.1
—
0
9
(4027681)
5
30
1.67
0.61
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
281
1.26
0.61
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
64
1.57
0.59
2.5
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
53
1.52
0.58
1.4
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
31
247
1.27
0.58
2.6
2.7
g/l
128.2
130.3
0.21
31
242
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
35
1.72
0.58
1.5
1.5
u/ml
0.6
1.4
—
6
20
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.57
1.2
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
(4010399)
38
312
1.24
0.56
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.56
2.5
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
65
1.55
0.56
2.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
415
0.81
0.55
1.6
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
133
1219
1.12
0.53
3.0
3.2
mg/l
1260.5
162.9
0.89
91
765
(3025130) Human papilloma virus identified in Specimen
6
40
1.51
0.51
1.3
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
135
1.35
0.51
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
75
1.48
0.51
1.7
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
101
1.40
0.50
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
106
0.66
0.49
2.0
4.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
108
0.64
0.49
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
166
0.72
0.48
4.8
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
166
0.72
0.48
4.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
46
1.53
0.48
1.3
3.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.9
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
165
0.72
0.47
4.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
164
0.73
0.45
5.2
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
825
1.13
0.44
1.5
1.6
pmol/l
83951051.7
7289067.0
0.44
81
686
(40761536) Microorganisms panel - Urine sediment
35
294
1.20
0.44
4.6
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
95
1.38
0.44
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
131
0.68
0.43
6.1
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
203
1.24
0.43
2.3
2.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
92
0.65
0.42
1.5
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
35.0
—
0
10
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.4
g/l
1.1
1.0
—
5
34
(3004616) Nuclear Ab [Presence] in Serum
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
8.8
—
0
18
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
61
1.32
0.39
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
71
1.42
0.39
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
482
0.86
0.39
1.5
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
433
4257
1.13
0.38
5.2
4.9
mmol/l
2.7
2.8
0.24
405
3945
(3019309) Folate [Moles/volume] in Red Blood Cells
78
708
1.12
0.38
1.7
1.7
nmol/l
1304.6
1203.7
0.21
61
536
(3001019) Free T4 and TSH panel - Serum or Plasma
25
207
1.22
0.37
1.9
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.7
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
73
1.38
0.34
1.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
155
0.77
0.33
4.8
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
120
1124
1.09
0.33
2.0
1.6
mmol/l
1.4
1.4
0.06
108
953
(40768443) Skin Pathology biopsy report
18
146
1.24
0.32
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
248
1.18
0.32
3.7
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
52
1.35
0.31
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
98
0.71
0.31
2.6
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
56
1.25
0.29
1.3
3.1
e9/l
4.4
4.3
—
7
56
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
57
1.23
0.29
1.6
3.5
%
57.1
57.0
—
7
57
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
432
1.12
0.28
1.6
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
158
1.21
0.28
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
63
1.27
0.28
2.6
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
73
0.68
0.26
1.4
1.1
—
—
—
0
0
(1002224) Polysomnography panel
16
192
0.83
0.26
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
424
4185
1.09
0.25
4.7
4.5
mmol/l
4.6
4.7
0.18
400
3895
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
(4094501)
14
115
1.22
0.23
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
12
97
1.24
0.23
1.3
1.6
e6/l
4255.1
10255.3
—
7
70
(3039443) Prostate specific Ag panel - Serum or Plasma
7
95
0.73
0.22
1.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
2.0
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
9.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
6.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
102
0.78
0.21
5.3
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
1.5
—
0
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(44806420)
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
2.0
1.7
—
—
—
0
0
(4146454)
6
48
1.25
0.20
2.7
3.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
49
1.23
0.20
3.0
2.6
u/ml
—
548.1
—
0
7
(21494755) Public health laboratory ask at order entry panel
39
426
0.91
0.19
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
43
395
1.10
0.19
1.7
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
53
1.13
0.18
1.7
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
70
0.71
0.17
2.0
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
1057
1.05
0.16
4.2
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
137
1325
1.05
0.15
3.3
3.1
mmol/l
7.7
7.8
0.10
119
1113
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
606
1.06
0.15
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1291
1.04
0.13
3.5
4.0
mg/mmol
3.9
8.1
1.82
90
807
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
405
4017
1.04
0.11
4.2
4.0
mmol/l
1.3
1.3
0.60
376
3693
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
105
1.15
0.11
1.4
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
105
1.15
0.11
1.2
1.2
—
9.5
—
0
9
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
419
4160
1.04
0.11
4.7
4.4
mmol/l
1.5
1.5
0.05
392
3850
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
47
1.06
0.09
1.6
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
73
706
1.04
0.09
2.1
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
61
0.82
0.08
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
62
0.80
0.08
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
88
1.14
0.08
2.0
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
47
490
0.95
0.08
2.3
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
500
1.04
0.08
31.6
22.0
inr
1.4
1.2
—
8
73
(3021788) Differential panel - Synovial fluid
8
74
1.08
0.07
1.3
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
47
488
0.96
0.07
3.1
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
169
1.07
0.05
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
150
0.93
0.04
2.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
111
1.08
0.04
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
73
741
0.98
0.02
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
560
1.02
0.02
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
439
0.98
0.02
2.9
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
93
1.08
0.02
2.7
2.7
mmol/l
25.6
25.2
—
10
82
(3019832) Treponema pallidum Ab [Presence] in Serum
37
378
0.98
0.01
2.0
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
163
1.04
0.01
1.2
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
20
194
1.03
0.00
3.1
2.5
mmol/l
25.6
25.3
0.17
20
186
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
109
1.01
0.00
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
199
1.01
0.00
2.0
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
78.9
—
0
8
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
78
0.90
0.00
7.6
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(3044941) Cell count panel - Synovial fluid
6
62
0.97
0.00
1.2
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
72
0.97
0.00
8.4
5.5
umol/l
416.7
377.8
—
7
65
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
61
0.98
0.00
1.5
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
120
1.00
0.00
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
68
0.88
0.00
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
69
0.87
0.00
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
298.9
—
0
7
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
50
1.00
0.00
1.0
2.2
umol/l
3.7
3.3
—
5
33
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
64
0.94
0.00
1.2
1.2
—
75.1
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SPINAL_CORD_EXALLC – Benign neoplasm: Spinal cord
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).